Tempest Therapeutics. Every tracked FinTwit mention of $TPST, newest first. 4 mentions since the first on Nov 19, 2025. See the price chart.
February 2026 · 1 mention
Feb 11
Jacob Plieth — The enlarged $TPST prioritising a CD19 x BCMA Car-T (TPST-2003), just as $AZN launches its phase 3 study of (ex $GRCL) AZD0120/GC012F: https://t.co/o5QBIUWIS7↗
November 2025 · 3 mentions
Nov 20
Jacob Plieth — Is it a reverse merger? Is it a fund raising? I've tried to decipher the $TPST Factor deal, which is structured to avoid litigation vs $CLLS & $AZN. Via @ApexOnco -> https:/…↗
Nov 19
Jacob Plieth — And yes, Factor Bioscience is in dispute vs $CLLS about the Talen technology $TPST https://t.co/NA8AofIvNh↗
Nov 19
Jacob Plieth — First I've heard of Factor Bioscience. Apparently uses mRNA to vectorise Talen tech. Pipeline from OncologyPipeline, but dual-acting Car-Ts including TPST-2003 (CD19 x BCMA Car) ap…↗